To assess the ability of sudemycin D1 to modulate spliceosome activity in CLL cells, we analyzed DNAJB1 expression as a surrogate marker for RNA splicing modulation [16]. Here, DNAJB1 is linked to B-cell chronic lymphocytic leukemia.